{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:31:07Z","timestamp":1744889467904},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jviromet.2024.115006","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:47:45Z","timestamp":1723096065000},"page":"115006","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An automated assay platform for the evaluation of antiviral compounds against polioviruses"],"prefix":"10.1016","volume":"329","author":[{"given":"Eric E.","family":"Rhoden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo A.","family":"Mainou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jviromet.2024.115006_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ofid\/ofv133.353","article-title":"Use of investigational antiviral drug pocapavir to treat enteroviral sepsis in twin neonates","volume":"2","author":"Cataldi","year":"2015","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.jviromet.2024.115006_bib2","first-page":"335","article-title":"Hartford Marianne, Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model","volume":"215","author":"Collett","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2024.115006_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2008.04.002","article-title":"A case for developing antiviral drugs against polio","volume":"79","author":"Collett","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2024.115006_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3201\/eid1404.070439","article-title":"Potential use of antiviral agents in polio eradication","volume":"14","author":"De Palma","year":"2008","journal-title":"Emerg. Infect. Dis."},{"issue":"24","key":"10.1016\/j.jviromet.2024.115006_bib5","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","article-title":"Vaccine-derived poliomyelitis 12 years after infection in Minnesota","volume":"364","author":"DeVries","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jviromet.2024.115006_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal."},{"key":"10.1016\/j.jviromet.2024.115006_bib7","unstructured":"Food and Drug Adminstration. Guidance for industry: bioanalytical method validation.\u3008http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070107.pdf\u3009."},{"issue":"1","key":"10.1016\/j.jviromet.2024.115006_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-101416-041749","article-title":"Breaking the last chains of poliovirus transmission: progress and challenges in global polio eradication","volume":"5","author":"Kew","year":"2018","journal-title":"Annu. Rev. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.jviromet.2024.115006_bib9","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","article-title":"Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication","volume":"210","author":"McKinlay","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jviromet.2024.115006_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/adt.2013.513","article-title":"Development and validation of a 96-well cellular assay for the discovery of ALDH1A1 inhibitors","volume":"11","author":"Ming","year":"2013","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.jviromet.2024.115006_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1087057105283787","article-title":"'Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2'","volume":"11","author":"Miret","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jviromet.2024.115006_bib12","unstructured":"National Research Council. 2006. Exploring the role of antiviral drugs in the eradication of polio. The National Academies Press, Washington, DC."},{"key":"10.1016\/j.jviromet.2024.115006_bib13","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/AAC.00671-09","article-title":"In vitro antiviral activity of V-073 against polioviruses","volume":"53","author":"Oberste","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2024.115006_bib14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jviromet.2024.115006_bib15","first-page":"186","article-title":"Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds","volume":"98","author":"Rhoden","year":"2013","journal-title":"Antivirus\u00a0Res."},{"key":"10.1016\/j.jviromet.2024.115006_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/av.2024.12361","article-title":"Antiviral activity in vitro of double combinations of enteroviral inhibitors","volume":"vol 68","author":"Stoyanova","year":"2024","journal-title":"Acta Virol."},{"key":"10.1016\/j.jviromet.2024.115006_bib17","series-title":"Vaccines Saunders","first-page":"631","article-title":"Poliovirus vaccine live","author":"Sutter","year":"2008"},{"key":"10.1016\/j.jviromet.2024.115006_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.07.003","article-title":"H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1","volume":"110","author":"Tijsma","year":"2014","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.jviromet.2024.115006_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/INF.0000000000000497","article-title":"First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis","volume":"34","author":"Torres-Torres","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"8","key":"10.1016\/j.jviromet.2024.115006_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/adt.2013.529","article-title":"An automated time-of-addition assay to routinely determine the mode of action of HIV-1 inhibitors","volume":"11","author":"Van Loock","year":"2013","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.jviromet.2024.115006_bib21","unstructured":"WHO Global Action Plan for Poliovirus Containment. 2022. (polioeradication.org\/wp-content\/uploads\/2022\/07\/GPCAP-2022-2024.pdf)."},{"key":"10.1016\/j.jviromet.2024.115006_bib22","unstructured":"Worzella, T., Larson, B.A., 2003. Automating Promega cell-based assays in multiwell formats. Promega Corporation application note Number 85.."},{"key":"10.1016\/j.jviromet.2024.115006_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jviromet.2024.115006_bib24","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1038\/s41598-019-42160-7","article-title":"Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T07:13:07Z","timestamp":1725261187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093424001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"alternative-id":["S0166093424001307"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115006","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An automated assay platform for the evaluation of antiviral compounds against polioviruses","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115006"}}